Clinical Trial: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Long-term Quality of Life Symptom Burden in Acute Promyelocytic Leukemia (APL) Patients Treated With Arsenic Trioxide (ATO) or Standard Chemotherapy

Brief Summary: This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.